Atlas Trials

A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension

Clinical trial NCT01970059 · UNKNOWN

Trial details

NCT number
NCT01970059
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2013-10-01
Primary completion
2013-10-01
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.